Skip to main content
Signal8
Pomeroy Claire profile photo

Claire Pomeroy

CIK: 0001603648

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

HAEMONETICS CORP logo
HAE

HAEMONETICS CORP

Director
Embecta Corp. logo
EMBC

Embecta Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • HAEMONETICS CORP logo
    HAE

    HAEMONETICS CORP

    Jul 24, 2026
    Award(A)
    Direct
    2.5K shares-
  • Embecta Corp. logo
    EMBC

    Embecta Corp.

    Feb 11, 2026
    Award(A)
    Direct
    22.8K shares-
  • HAEMONETICS CORP logo
    HAE

    HAEMONETICS CORP

    Jul 24, 2025
    Award(A)
    Direct
    2.7K shares-
  • Embecta Corp. logo
    EMBC

    Embecta Corp.

    Feb 12, 2025
    Award(A)
    Direct
    13.8K shares-

1-4 of 4

About Pomeroy Claire

Pomeroy Claire (SEC CIK 0001603648) files insider reports with the SEC as Director of HAEMONETICS CORP (HAE) and Director of Embecta Corp. (EMBC).

Signal8 holds 4 ownership filings by Pomeroy Claire, all Form 4s, filed between Feb 14, 2025 and Jul 28, 2026. Those filings report 4 transactions, from Feb 12, 2025 to Jul 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Pomeroy Claire's filings is in BOSTON, MA.

Recent filings by Pomeroy Claire

  • Jul 24, 2026: Grant or award of HAE shares (Form 4, code A).
  • Feb 11, 2026: Grant or award of EMBC shares (Form 4, code A).
  • Jul 24, 2025: Grant or award of HAE shares (Form 4, code A).
  • Feb 12, 2025: Grant or award of EMBC shares (Form 4, code A).

Other insiders filing for HAEMONETICS CORP (HAE)

How to read Form 4 transaction codes